[ET Net News Agency, 19 November 2026] LUYE PHARMA (02186) fell 2.6% to HK$1.5.
It hits an intra-day low of HK$1.5, hitting a historical low, and an intra-day high of HK$1.535. The total shares traded was 696,007, with a value of HK$1.05m. The active buy/sell ratio is 19:81, with net selling turnover of HK$640,265. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$364,779, with volume weighted average price of HK$1.506. BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$44,623, with volume weighted average price of HK$1.504.
Basic Information| Nominal | 1.500 | % Chg | -2.60% |
| High | 1.535 | Low | 1.500 |
| Shares Tr | 696,007 | Turnover | 1.05m |
| 10-D SMA | 1.604 | %H.V | 36.572 |
| 20-D SMA | 1.605 | VWAP | 1.506 |
| 50-D SMA | 1.711 | RSI14 | 30.118 |
Status: Hitting a historical low, active buy/sell ratio is 19:81, with net selling turnover of HK$640,265
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| LUYE PHARMA (02186) | 1.500 | -2.60 |
| SIHUAN PHARM (00460) | 0.720 | -2.04 |
| GRAND PHARMA (00512) | 4.230 | -1.40 |
| SBP GROUP (01177) | 5.345 | -1.29 |
| HENGRUI PHARMA (01276) | 46.340 | -0.52 |
| LIVZON PHARMA (01513) | 24.860 | -0.48 |
| FOSUN PHARMA (02196) | 14.910 | -1.32 |
| SH PHARMA (02607) | 10.940 | -0.45 |
| CHINARES PHARMA (03320) | 4.485 | -0.33 |
| HANSOH PHARMA (03692) | 32.600 | -0.31 |
(ed)